King's College London

Research portal

One-Pot Radiosynthesis and Biological Evaluation of a Caspase-3 Selective 5-[123,125I]iodo-1,2,3-triazole derived Isatin SPECT Tracer

Research output: Contribution to journalArticle

Matthias Glaser, Vineeth Rajkumar, Seckou Diocou, Thibault Gendron, Ran Yan, Pak Kwan Brian Sin, Kerstin Sander, Laurence Carroll, R Barbara Pedley, Eric O Aboagye, Timothy H Witney, Erik Årstad

Original languageEnglish
Article number19299
Pages (from-to)19299
JournalScientific Reports
Volume9
Issue number1
DOIs
Publication statusPublished - 17 Dec 2019

Documents

  • s41598-019-55992-0

    s41598_019_55992_0.pdf, 2.43 MB, application/pdf

    25/12/2019

    Final published version

    CC BY-ND

King's Authors

Abstract

Induction of apoptosis is often necessary for successful cancer therapy, and the non-invasive monitoring of apoptosis post-therapy could assist in clinical decision making. Isatins are a class of compounds that target activated caspase-3 during apoptosis. Here we report the synthesis of the 5-iodo-1,2,3-triazole (FITI) analog of the PET tracer [18F]ICMT11 as a candidate tracer for imaging of apoptosis with SPECT, as well as PET. Labelling with radioiodine (123,125I) was achieved in 55 ± 12% radiochemical yield through a chelator-accelerated one-pot cycloaddition reaction mediated by copper(I) catalysis. The caspase-3 binding affinity and selectivity of FITI compares favourably to that of [18F]ICMT11 (Ki = 6.1 ± 0.9 nM and 12.4 ± 4.7 nM, respectively). In biodistribution studies, etoposide-induced cell death in a SW1222 xenograft model resulted in a 2-fold increase in tumour uptake of the tracer. However, the tumour uptake was too low to allow in vivo imaging of apoptosis with SPECT.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454